![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
Sia Daneshmand, M.D.
@siadaneshmand
Professor of Urology and Oncology (Clinical Scholar)
Director of Urologic Oncology
Director of Clinical Research
Urologic Oncology Fellowship Director
USC
ID:49533860
22-06-2009 04:17:54
707 Tweets
3,2K Followers
587 Following
![Andrew J. Hung, MD(@AjhungMD) 's Twitter Profile Photo Andrew J. Hung, MD(@AjhungMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1326944617028227072/buJar4z-_200x200.jpg)
YES, our team has been busy
Third paper to announce in 7 days
Our FIRST take on automating suturing skills assessment #SurgicalAI
FREE access rdcu.be/cYhrS
Funded by National Cancer Institute #R01 #DeepStitch
Prof. Anima Anandkumar Caltech De-An Huang NVIDIA AI
![Andrew J. Hung, MD (@AjhungMD) on Twitter photo 2022-10-26 03:04:37 YES, our team has been busy Third paper to announce in 7 days Our FIRST take on automating suturing skills assessment #SurgicalAI FREE access rdcu.be/cYhrS Funded by @theNCI #R01 #DeepStitch @AnimaAnandkumar @Caltech @deanh_tw @NVIDIAAI YES, our team has been busy Third paper to announce in 7 days Our FIRST take on automating suturing skills assessment #SurgicalAI FREE access rdcu.be/cYhrS Funded by @theNCI #R01 #DeepStitch @AnimaAnandkumar @Caltech @deanh_tw @NVIDIAAI](https://pbs.twimg.com/media/Ff9sDj8UcAE-8PX.png)
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
![Simon Kim, MD, MPH(@simon_p_kim) 's Twitter Profile Photo Simon Kim, MD, MPH(@simon_p_kim) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1271570927176818690/qMeumluu_200x200.jpg)
![Journal of Clinical Oncology(@JCO_ASCO) 's Twitter Profile Photo Journal of Clinical Oncology(@JCO_ASCO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1457711669380108289/0p_UOu4t_200x200.jpg)
๐ Enfortumab vedotin + pembro as 1st-line tx for metastatic #UrothelialCancer yields response rate of 73.3%, duration of response 25.6 mo, overall survival 26.1 mo.ย ๐ fal.cn/3sEjU #JCO #blcsm #kcsm #gucsm Jonathan Rosenberg MD
![Journal of Clinical Oncology (@JCO_ASCO) on Twitter photo 2022-10-11 20:25:02 ๐ Enfortumab vedotin + pembro as 1st-line tx for metastatic #UrothelialCancer yields response rate of 73.3%, duration of response 25.6 mo, overall survival 26.1 mo.ย ๐ fal.cn/3sEjU #JCO #blcsm #kcsm #gucsm @DrRosenbergMSK ๐ Enfortumab vedotin + pembro as 1st-line tx for metastatic #UrothelialCancer yields response rate of 73.3%, duration of response 25.6 mo, overall survival 26.1 mo.ย ๐ fal.cn/3sEjU #JCO #blcsm #kcsm #gucsm @DrRosenbergMSK](https://pbs.twimg.com/media/Fe0K9qqWYBkkMdM.jpg)
![Kathleen Kobashi(@KKseattle) 's Twitter Profile Photo Kathleen Kobashi(@KKseattle) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1250855872546275333/Tz66NocR_200x200.jpg)
Western Section AUA will host Women of the WSAUA in Kauai. ๐ ALL are welcome! Thank you, @preyblat, for spearheading this wonderful initiative! Sia Daneshmand, M.D. #ChrisPorter Christopher J. Kane Christopher Amling Amer. Urol. Assn. Kaiser Permanente Urology Casey Seideman MD
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
Iranian women are among the most educated and accomplished around the world. Help support the movement #mahsaamini #womenofiran #womensrights #iranpotests instagram.com/p/CjN0fKorqXJ/โฆ
![Carolyn Meltzer, MD(@DeanMeltzer) 's Twitter Profile Photo Carolyn Meltzer, MD(@DeanMeltzer) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1498357334443114497/xwjZ3ss7_200x200.jpg)
![Morteza Dehghani(@MortezDehghani) 's Twitter Profile Photo Morteza Dehghani(@MortezDehghani) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1192302626144043008/4GZUy9MB_200x200.jpg)
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
Indeed well done trial. ๐ Several caveats to consider: #1 Vast majority IR highlighted by Saum Ghodoussipour #2 low CIS (11-13%) where BL best. #3 wide CI 0.69-1.28 #4 BL performed once at start. RFS curves in favor of BL up to 12-15 mos. Would RFS have diverged if f/u also done with BL?
![Sia Daneshmand, M.D. (@siadaneshmand) on Twitter photo 2022-10-05 05:46:55 Indeed well done trial. ๐ Several caveats to consider: #1 Vast majority IR highlighted by @saumyg #2 low CIS (11-13%) where BL best. #3 wide CI 0.69-1.28 #4 BL performed once at start. RFS curves in favor of BL up to 12-15 mos. Would RFS have diverged if f/u also done with BL? Indeed well done trial. ๐ Several caveats to consider: #1 Vast majority IR highlighted by @saumyg #2 low CIS (11-13%) where BL best. #3 wide CI 0.69-1.28 #4 BL performed once at start. RFS curves in favor of BL up to 12-15 mos. Would RFS have diverged if f/u also done with BL?](https://pbs.twimg.com/media/FeSIb6FVIAI3V0j.jpg)
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
Oldies but goodies. Stephen Boorjian, MD Mayo Clinic Urology USC series ncbi.nlm.nih.gov/pubmed/15538242 Mayo series. ncbi.nlm.nih.gov/pubmed/17631342 Some with limited nodes can be cured. We still see them in clinic!
![Sia Daneshmand, M.D. (@siadaneshmand) on Twitter photo 2022-10-05 05:11:11 Oldies but goodies. @SBoorjian @MayoUrology USC series ncbi.nlm.nih.gov/pubmed/15538242 Mayo series. ncbi.nlm.nih.gov/pubmed/17631342 Some with limited nodes can be cured. We still see them in clinic! Oldies but goodies. @SBoorjian @MayoUrology USC series ncbi.nlm.nih.gov/pubmed/15538242 Mayo series. ncbi.nlm.nih.gov/pubmed/17631342 Some with limited nodes can be cured. We still see them in clinic!](https://pbs.twimg.com/media/FeSAQqRVsAEPOe0.jpg)
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
![Bernie Bochner, MD(@bbmdmsk) 's Twitter Profile Photo Bernie Bochner, MD(@bbmdmsk) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1436148201149636612/Vn3zh64I_200x200.jpg)
DrBagrodia Sam S. Chang MD, MBA Sia Daneshmand, M.D. Anne Schuckman Amir Salmasi Eugene Pietzak Solomon Woldu Jay B. Shah Angie Smith Agree with DrBagrodia If extraperitoneal, just a cath until healed (confirm with cystogram). If resection was incomplete, go back and finish resection once healing is complete.
I donโt keep them abx just cover when the cath is removed.
![Shilpa Gupta(@shilpaonc) 's Twitter Profile Photo Shilpa Gupta(@shilpaonc) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1439611610092421126/NNouObVs_200x200.jpg)
Sumanta Pal Uromigos ๐alison birtle Tom Powles Neeraj Agarwal Brian Rini, MD Sia Daneshmand, M.D. Vadim Koshkin MD Very interesting indeed! An unmet need to do novel biomarker-driven adjuvant trials like PROOF-302 trial exploring the role of FGFR inhibition in pts with FGFR3 alterations.
clinicaltrials.gov/ct2/show/NCT04โฆ
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
![Paul Sargos(@PaulSargos) 's Twitter Profile Photo Paul Sargos(@PaulSargos) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1200754588732841984/bTsqSOBv_200x200.jpg)
Really to proud to be a speaker at the first #sogocon meeting in Bangalore, #india , next week.
๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ
Unfortunately, Virtual ๐.
๐๐Great expert panel Vedang Murthy Amar Kishan Sia Daneshmand, M.D. Prof Ananya๐
โ๏ธThanks a lot Vedang Murthy for this invitation.
![Paul Sargos (@PaulSargos) on Twitter photo 2022-08-20 07:23:23 Really to proud to be a speaker at the first #sogocon meeting in Bangalore, #india, next week. ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ Unfortunately, Virtual ๐. ๐๐Great expert panel @VedangMurthy @AmarUKishan @siadaneshmand @achoud72 โ๏ธThanks a lot @VedangMurthy for this invitation. Really to proud to be a speaker at the first #sogocon meeting in Bangalore, #india, next week. ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ๐ฎ๐ณ Unfortunately, Virtual ๐. ๐๐Great expert panel @VedangMurthy @AmarUKishan @siadaneshmand @achoud72 โ๏ธThanks a lot @VedangMurthy for this invitation.](https://pbs.twimg.com/media/FallYakWIAAYE3C.jpg)
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)
![Bernie Bochner, MD(@bbmdmsk) 's Twitter Profile Photo Bernie Bochner, MD(@bbmdmsk) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1436148201149636612/Vn3zh64I_200x200.jpg)
![Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo Sia Daneshmand, M.D.(@siadaneshmand) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1563771303043014657/CgweJW-S_200x200.jpg)